During EMT, tumor cells gradually lose the epithelial markers (E-cadherin, tight junction protein-1, laminin and cytokeratin) and obtain the expression of mesenchymal markers (N-cadherin, Vimentin and α–SMA). The gene discussed is CDH2; the disease is neoplasm.